bupivacaine and methylprednisolone

ApprovedSmall molecule

BBursa Yuksek Ihtisas Training and Research Hospital

bupivacaine and methylprednisolone is one of 8 small molecule programs targeting Shoulder Impingement Syndrome. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Shoulder Impingement SyndromeActive, not recruiting

Shoulder Impingement SyndromeApproved

Active, not recruiting

Competition

Competitive Landscape

9 competitors in Shoulder Impingement Syndrome

#DrugCompanyPhaseTrials

Toradol

Xylocaine

Kenalog

BBausch Health Americas, Inc.

Phase 2

1 4

bupivacaine and methylprednisolone

BBursa Yuksek Ihtisas Training and Research Hospital

Approved

1 5

Synera

ZZARS Pharma Inc.

Phase 2

1 6

Toradol

JJavelin Pharmaceuticals

Preclinical

1 7

Kenalog

BBassett Healthcare

Preclinical

1 8

LAENNEC

GGreen Cross Wellbeing

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Shoulder Impingement Syndrome1 trial

Comparison of the Effectiveness of the Ultrasound Guided Injections in Patients With Shoulder Impingement Syndrome

Completed·—·Phase 4·NCT05015322·88 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for bupivacaine and methylprednisolone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — bupivacaine and methylprednisolone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for bupivacaine and methylprednisolone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Bursa Yuksek Ihtisas Training and Research Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: BBursa Yuksek Ihtisas Training and Research Hospital

bupivacaine and methylprednisolone

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Shoulder Impingement Syndrome1 trial

References

Drug Info

Quick Facts

Related News